Whereas the 'infectious disease hypothesis' suggesting a causal role for various agents (in particular Chlamydia pneumoniae) in the process of atherogenesis has been abandoned more than a decade ago after the failure of several antibiotic trials, 1 compelling evidence has been accumulated from epidemiological studies that bacterial infections of the respiratory tract (e.g. pneumonia) can acutely trigger the occurrence of cardiovascular events, such as myocardial infarction (MI) and stroke. 2, 3 Such observations have been extended to various infections in a large study looking into community acquired bacteraemia and cardiovascular disease (CVD) events. 4 Controversial evidence still exists regarding viral infections and CVD, 5 although vaccination against influenza has already been recommended by the European Society of Cardiology guidelines. 6 Mechanistically, infection, inflammation and alteration of the haemostatic system are intimately linked, so increased procoagulant activity, impaired response to nitric oxide, arrhythmias, reduced autonomic reflexes, and enhanced plaque inflammation might all contribute to increase CVD events acutely. 7 Yet, early observations have already called attention to chronic respiratory infections and the ncreased risk of a first MI long term. 8 However, whether previous acute severe infections also alter long-term cardiovascular risk is less well investigated and mechanistic explanations for such delayed effects may go beyond simply a prolonged procoagulant activity. The large, well characterised register-based cohort study by Bergh et al. 9 with long-term follow-up and extensive control for confounding variables provides strong evidence for the notion that severe acute bacterial infections (e.g. pneumonia that requires inpatient care and sepsis) indeed raise the probability of a delayed occurrence of cardiovascular events. In particular, the authors found that the risk of experiencing a cardiovascular event is highest in the first year following an acute infection, subsequently declines over the years to follow, but still remains elevated five years after the index event.
This observation raises some intriguing questions as to what the underlying mechanisms for these observations are. CVD develops mainly through exacerbation of atherosclerosis. Atherosclerosis is a chronic metabolic and inflammatory disease of the vessel wall. 10 Inflammatory leukocytes, the effector cells of the immune system, are the main instigators of plaque inflammation and hence plaque destabilisation. Vulnerable plaques that are prone to rupture typically contain high numbers of inflammatory leukocytes. Inside plaques, leukocytes can promote the progression of atherosclerosis by: (a) thinning of the fibrous cap that separates the thrombogenic lipid core from the blood stream through the release of proteinases; and (b) expansion of the necrotic/lipid core through enhanced necrosis and apoptosis, and impaired efferocytosis. 11 In the setting of sterile inflammation, we recently gained mechanistic insights into how acute sterile inflammation at one specific location can fuel chronic sterile inflammation at another location. After MI as well as after stroke, acute ischaemia activates the sympathetic nervous system in the bone marrow, which in turn: (a) increases the production of leukocytes in the bone marrow (increased medullary haematopoiesis); 12 and (b) releases a surplus of haematopoietic stem and progenitor cells into the circulation. 13 These cells seed the spleen and begin to generate progeny (i.e. mature leukocytes) in a process called extramedullary haematopoiesis. This results in blood leukocytosis and as the supply of these cells is higher one also finds more of these cells inside atherosclerotic plaques (Figure 1 ). In accordance with this, blood leukocytosis has been long known to be an independent risk factor for cardiovascular morbidity and mortality. 14 After MI, plaque leukocyte numbers do not solely expand through an increase in supply from the blood. It was recently revealed that leukocyte uptake from the bloodstream into plaques is also aggravated after MI through local activation of plaque endothelial cells (Figure 1 ). 15 Previous MI activates the adventitial sympathetic nervous system in atherosclerotic vessels, leading to an upregulation of endothelial cell adhesion molecules and chemokines. MI-aggravated plaque leukocyte recruitment can be targeted using endothelial cell avid nanoparticles with encapsulated silent RNAs that silence the expression of five major cell adhesion molecules in parallel. 15 Future studies will reveal whether these mechanistic findings can be extrapolated from sterile to unsterile inflammation, and if and how acute bacterial infection (e.g. pneumonia) begets chronic sterile inflammation (e.g. atherosclerosis).
In summary, the report by Bergh et al. 9 shows that patients who suffered a severe bacterial infection are more likely to experience cardiovascular events not only acutely, but also in the years to follow. This observation should raise clinicians' awareness to more vulnerable patients after severe bacterial infection who may profit from early-on optimised cardiovascular care. Moreover, this study motivates future studies that aim to elucidate the underlying mechanisms better which may help with providing novel therapeutic strategies for patients after severe bacterial infections.
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